Related Experiment Video
Updated: Jan 6, 2026
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Association Between Peripheral Inflammation Biomarkers and Clinical Phenotypes in Patients With Medication Overuse
Changling Li1, Peiqi He1, Mengmeng Ma1
1Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Background:
The role of peripheral inflammation in medication overuse headache (MOH) remains inadequately understood. This study aimed to investigate biomarkers of peripheral inflammation in MOH patients and examine their relationship with clinical features.
Methods:
The study comprised 128 MOH patients and 132 age- and sex-matched controls, including 60 episodic migraine patients and 72 healthy controls (HC). Inflammatory markers derived from blood cell counts were assessed in all participants. Clinical features, including headache days and intensity per month and days per month with acute medication, were documented.
Results:
In MOH patients, the aggregate index of systemic inflammation (AISI) was higher compared to healthy controls, and both MOH and episodic migraine patients had elevated systemic inflammation response index (SIRI) levels. AISI and SIRI were positively correlated with the days per month with acute medication, while systemic inflammation index (SII), SIRI, AISI, and other inflammatory markers correlated with headache duration. AISI proved more effective than SII and SIRI in diagnosing MOH. Furthermore, elevated SII and AISI levels were significantly associated with MOH after adjusting for age and sex.
Conclusion:
The study found significant correlations between SII, SIRI, and AISI and clinical phenotypes in MOH. Elevated SII and AISI levels were significantly linked to MOH, implying that these peripheral inflammation biomarkers could enhance the understanding of MOH.
Insights
Peripheral inflammation markers like Systemic Inflammation Index (SII) and Aggregate Index of Systemic Inflammation (AISI) are linked to medication overuse headache (MOH). Elevated levels of these biomarkers are associated with MOH and its clinical features.
Area of Science:
- Neurology
- Immunology
- Biomarker Research
Background:
- Peripheral inflammation's role in medication overuse headache (MOH) is not well understood.
- Investigating inflammatory biomarkers in MOH patients is crucial for understanding disease mechanisms.
Purpose of the Study:
- To investigate peripheral inflammation biomarkers in MOH patients.
- To examine the relationship between these biomarkers and clinical features of MOH.
Main Methods:
- Assessed inflammatory markers from blood cell counts in 128 MOH patients and 132 controls (60 episodic migraine, 72 healthy).
- Documented clinical features including headache frequency, intensity, and acute medication use.
Main Results:
- MOH patients showed higher Aggregate Index of Systemic Inflammation (AISI) than healthy controls.
- Systemic Inflammation Index (SII), SIRI, and AISI correlated with headache duration and acute medication use.
- AISI was more effective than SII and SIRI in diagnosing MOH; elevated SII and AISI were significantly associated with MOH.
Conclusions:
- Significant correlations exist between SII, SIRI, AISI, and MOH clinical phenotypes.
- Elevated SII and AISI levels are significantly linked to MOH.
- Peripheral inflammation biomarkers can enhance the understanding and diagnosis of MOH.
